In vivo SELEX of an inhibitory NSCLC-specific RNA aptamer from PEGylated RNA library H Wang, Y Zhang, H Yang, M Qin, X Ding, R Liu, Y Jiang Molecular Therapy-Nucleic Acids 10, 187-198, 2018 | 57 | 2018 |
Formulation and in vitro stability evaluation of ethosomal carbomer hydrogel for transdermal vaccine delivery Y Zhang, W Ng, J Hu, SS Mussa, Y Ge, H Xu Colloids and surfaces B: Biointerfaces 163, 184-191, 2018 | 51 | 2018 |
Lipid vesicular nanocarrier: quick encapsulation efficiency determination and transcutaneous application Y Zhang, W Ng, X Feng, F Cao, H Xu International Journal of Pharmaceutics 516 (1-2), 225-230, 2017 | 45 | 2017 |
Serum tumor marker detection on PEGylated lipid membrane using biosensor based on total internal reflection imaging ellipsometry Y Zhang, Y Chen, G Jin Sensors and Actuators B: Chemical 159 (1), 121-125, 2011 | 32 | 2011 |
Correlation between Membrane Partitioning and Functional Activity in a Single Lipid Vesicle Assay Establishes Design Guidelines for Antiviral Peptides. JA Jackman, R Saravanan, Y Zhang, SR Tabaei, NJ Cho Small (Weinheim an der Bergstrasse, Germany) 11 (20), 2372-2379, 2015 | 31 | 2015 |
Differential Modulating Effect of MoS2 on Amyloid Peptide Assemblies J Wang, L Liu, D Ge, H Zhang, Y Feng, Y Zhang, M Chen, M Dong Chemistry–A European Journal 24 (14), 3397-3402, 2018 | 22 | 2018 |
PEGylated phospholipid membrane on polymer cushion and its interaction with cholesterol Y Zhang, Y Chen, G Jin Langmuir 26 (13), 11140-11144, 2010 | 14 | 2010 |
Chitosan cushioned phospholipid membrane and its application in imaging ellipsometry based-biosensor Y Zhang, Y Chen, G Jin Applied surface science 257 (22), 9407-9413, 2011 | 11 | 2011 |
One-pot synthesis and characterization of ovalbumin-conjugated gold nanoparticles: a comparative study of adjuvanticity against the physical mixture of ovalbumin and gold … Y Yang, Y Zhang, A Thakur, R Li, H Xu, Z Wang, M Ghavami, Z Tu, H Liu International Journal of Pharmaceutics 571, 118704, 2019 | 10 | 2019 |
Targeting membrane receptors of ovarian cancer cells for therapy Z Liang, Z Lu, Y Zhang, D Shang, R Li, L Liu, Z Zhao, P Zhang, Q Lin, ... Current Cancer Drug Targets 19 (6), 449-467, 2019 | 8 | 2019 |
Poly (ADP-ribose) polymerase inhibitors combined with other small-molecular compounds for the treatment of ovarian cancer L Liu, P Liu, Z Liang, R Li, M Shen, H Xu, D Ren, M Ji, Y Yang, Z Lu, ... Anti-Cancer Drugs 30 (6), 554-561, 2019 | 2 | 2019 |